1,599
Views
51
CrossRef citations to date
0
Altmetric
Original Article

Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy

, , , , , , & show all
Pages 571-577 | Received 09 Apr 2008, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Tine B. Nyeng, Jesper F. Kallehauge, Morten Høyer, Jørgen B. B. Petersen, Per R. Poulsen & Ludvig P. Muren. (2011) Clinical validation of a 4D-CT based method for lung ventilation measurement in phantoms and patients. Acta Oncologica 50:6, pages 897-907.
Read now
Berit M. Wennberg, Pia Baumann, Giovanna Gagliardi, Jan Nyman, Ninni Drugge, Morten Hoyer, Anders Traberg, Kristina Nilsson, Elisabeth Morhed, Lars Ekberg, Lena Wittgren, Jo-Åsmund Lund, Nina Levin, Christer Sederholm, Rolf Lewensohn & Ingmar Lax. (2011) NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction. Acta Oncologica 50:4, pages 518-527.
Read now
Mike Partridge, Tokihiro Yamamoto, Cai Grau, Morten Høyer & Ludvig Paul Muren. (2010) Imaging of normal lung, liver and parotid gland function for radiotherapy. Acta Oncologica 49:7, pages 997-1011.
Read now

Articles from other publishers (48)

David J. MurphyMaria MayoralAnna R. LariciMichelle S. GinsbergGiuseppe CicchettiFlorian J. FintelmannEdith M. MaromMylene T. TruongRitu R. Gill. (2023) Imaging Follow-Up of Nonsurgical Therapies for Lung Cancer: AJR Expert Panel Narrative Review . American Journal of Roentgenology, pages 1-16.
Crossref
Nozomi Kita, Natsuo Tomita, Taiki Takaoka, Dai Okazaki, Masanari Niwa, Akira Torii, Seiya Takano, Yuji Mekata, Akio Niimi & Akio Hiwatashi. (2023) Clinical and dosimetric factors for symptomatic radiation pneumonitis after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Clinical and Translational Radiation Oncology 41, pages 100648.
Crossref
A. Beddok, M. Loi, E. Rivin Del Campo, J.-L. Dumas, A. Orthuon, G. Créhange & F. Huguet. (2023) Limites de la définition des contraintes de dose pour les organes à risque spécifiques à la radiothérapie stéréotaxique. Cancer/Radiothérapie 27:4, pages 341-348.
Crossref
Frances Mark, Anoud Alnsour, Scott N. Penfold, Adrian Esterman, Robert Keys & Hien Le. (2022) Volumetric modulated arc therapy ( VMAT ) comparison to 3D ‐conformal technique in lung stereotactic ablative radiotherapy ( SABR ) . Journal of Medical Radiation Sciences 70:1, pages 72-80.
Crossref
Ying Huang, Aihui Feng, Yang Lin, Hengle Gu, Hua Chen, Hao Wang, Yan Shao, Yanhua Duan, Weihai Zhuo & Zhiyong Xu. (2022) Radiation pneumonitis prediction after stereotactic body radiation therapy based on 3D dose distribution: dosiomics and/or deep learning-based radiomics features. Radiation Oncology 17:1.
Crossref
C.D. Strange, G.S. Shroff, M.T. Truong, Q.-N. Nguyen, I. Vlahos & J.J. Erasmus. (2022) Imaging of the post-radiation chest in lung cancer. Clinical Radiology 77:1, pages 19-30.
Crossref
Khaled Bousabarah, Oliver Blanck, Susanne Temming, Maria-Lisa Wilhelm, Mauritius Hoevels, Wolfgang W. Baus, Daniel Ruess, Veerle Visser-Vandewalle, Maximilian I. Ruge, Harald Treuer & Martin Kocher. (2021) Radiomics for prediction of radiation-induced lung injury and oncologic outcome after robotic stereotactic body radiotherapy of lung cancer: results from two independent institutions. Radiation Oncology 16:1.
Crossref
Feng-Ming (Spring) Kong, Vitali Moiseenko, Jing Zhao, Michael T. Milano, Ling Li, Andreas Rimner, Shiva Das, X. Allen Li, Moyed Miften, ZhongXing Liao, Mary Martel, Soren M. Bentzen, Andrew Jackson, Jimm Grimm, Lawrence B. Marks & Ellen Yorke. (2021) Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?. International Journal of Radiation Oncology*Biology*Physics 110:1, pages 172-187.
Crossref
Gang Liu, Lewei Zhao, An Qin, Inga Grills, Rohan Deraniyagala, Craig Stevens, Sheng Zhang, Di Yan, Xiaoqiang Li & Xuanfeng Ding. (2021) Lung Stereotactic Body Radiotherapy (SBRT) Using Spot-Scanning Proton Arc (SPArc) Therapy: A Feasibility Study. Frontiers in Oncology 11.
Crossref
Yongmei Liu, Weili Wang, Kevin Shiue, Huan Yao, Alberto Cerra-Franco, Ronald H. Shapiro, Ke Colin Huang, Douglas Vile, Mark Langer, Gordon Watson, Greg Bartlett, Huisi Ai, Francis Sheski, Jian-Yue Jin, Rich Zellars, Pingfu Fu, Tim Lautenschlaeger & Feng-Ming (Spring) Kong. (2021) Risk factors for symptomatic radiation pneumonitis after stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer. Radiotherapy and Oncology 156, pages 231-238.
Crossref
Jeffrey M. Ryckman, Michael Baine, Joseph Carmicheal, Ferdinand Osayande, Richard Sleightholm, Kaeli Samson, Dandan Zheng, Weining Zhen, Chi Lin & Chi Zhang. (2020) Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy. Radiation Oncology 15:1.
Crossref
I. Menoux, D. Antoni, N. Santelmo, P. Truntzer, C. Schumacher, A. Labani & G. Noël. (2019) Radiographic findings after stereotactic body radiation therapy for stage I non-small cell lung carcinomas: retrospective analysis of 90 patients. Journal of Radiotherapy in Practice 19:4, pages 333-340.
Crossref
I. Menoux, D. Antoni, C. Mazzara, A. Labani, A. Charloux, E. Quoix, P.-E. Falcoz, P. Truntzer & G. Noël. (2020) Radiation-induced lung toxicity predictors: Retrospective analysis of 90 patients treated with stereotactic body radiation therapy for stage I non-small-cell lung carcinoma. Cancer/Radiothérapie 24:2, pages 120-127.
Crossref
Giuseppe Palma, Serena Monti, Manuel Conson, Roberto Pacelli & Laura Cella. (2019) Normal tissue complication probability (NTCP) models for modern radiation therapy. Seminars in Oncology 46:3, pages 210-218.
Crossref
Sean M. Parker, R. Alfredo Siochi, Sijin Wen & Malcolm D. Mattes. (2019) Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors. Practical Radiation Oncology 9:1, pages e90-e97.
Crossref
Chi Lu, Zhang Lei, Hongbin Wu & Hongda Lu. (2018) Evaluating risk factors of radiation pneumonitis after stereotactic body radiation therapy in lung tumor: Meta-analysis of 9 observational studies. PLOS ONE 13:12, pages e0208637.
Crossref
I. Menoux, D. Antoni, P. Truntzer, A. Keller, G. Massard & G. Noël. (2018) Stereotactic body radiation therapy for stage I non-small cell lung carcinomas: Moderate hypofractionation optimizes outcome. Lung Cancer 126, pages 201-207.
Crossref
I. Menoux, C. Le Fèvre, G. Noël & D. Antoni. (2018) Facteurs prédictifs de toxicité pulmonaire après irradiation en conditions stéréotaxiques des carcinomes bronchopulmonaires non à petites cellules de stade I. Cancer/Radiothérapie 22:8, pages 826-838.
Crossref
Erkan Topkan, Ugur Selek, Yurday Ozdemir, Ali A. Besen, Ozan C. Guler, Berna A. Yildirim, Huseyin Mertsoylu, Alper Findikcioglu, Ozgur Ozyilkan & Berrin Pehlivan. (2018) Risk Factors for Fatal Pulmonary Hemorrhage following Concurrent Chemoradiotherapy in Stage 3B/C Squamous-Cell Lung Carcinoma Patients. Journal of Oncology 2018, pages 1-9.
Crossref
Christopher H. Chapman, Christopher McGuinness, Alexander R. Gottschalk, Sue S. Yom, Adam A. Garsa, Mekhail Anwar, Steve E. Braunstein, Atchar Sudhyadhom, Paul Keall & Martina Descovich. (2018) Influence of respiratory motion management technique on radiation pneumonitis risk with robotic stereotactic body radiation therapy. Journal of Applied Clinical Medical Physics 19:4, pages 48-57.
Crossref
Vanessa Figlia, Rosario Mazzola, Francesco Cuccia, Filippo Alongi, Gianluca Mortellaro, Daniela Cespuglio, Teresa Cucchiara, Giuseppina Iacoviello, Vito Valenti, Massimo Molino, Francesco Verderame, Domenica Matranga, Antonio Lo Casto & Giuseppe Ferrera. (2018) Hypo-fractionated stereotactic radiation therapy for lung malignancies by means of helical tomotherapy: report of feasibility by a single-center experience. La radiologia medica 123:6, pages 406-414.
Crossref
Tomoko Ueyama, Takeshi Arimura, Koji Takumi, Fumihiko Nakamura, Ryutaro Higashi, Soichiro Ito, Yoshihiko Fukukura, Tomokazu Umanodan, Masanori Nakajo, Chihaya Koriyama & Takashi Yoshiura. (2018) Risk factors for radiation pneumonitis after stereotactic radiation therapy for lung tumours: clinical usefulness of the planning target volume to total lung volume ratio. The British Journal of Radiology, pages 20170453.
Crossref
Jessica Lawrence & Richard Nho. (2018) The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis. International Journal of Molecular Sciences 19:3, pages 778.
Crossref
Marco D’Andrea, Silvia Strolin, Sara Ungania, Alessandra Cacciatore, Vicente Bruzzaniti, Raffaella Marconi, Marcello Benassi & Lidia Strigari. (2018) Radiobiological Optimization in Lung Stereotactic Body Radiation Therapy: Are We Ready to Apply Radiobiological Models?. Frontiers in Oncology 7.
Crossref
Serena Badellino, Jacopo Di Muzio, Giulia Schivazappa, Alessia Guarneri, Riccardo Ragona, Sara Bartoncini, Elisabetta Trino, Andrea Riccardo Filippi, Paolo Fonio & Umberto Ricardi. (2017) No differences in radiological changes after 3D conformal vs VMAT-based stereotactic radiotherapy for early stage non-small cell lung cancer . The British Journal of Radiology 90:1078, pages 20170143.
Crossref
Juliane Hörner-Rieber, Julian Dern, Denise Bernhardt, Laila König, Sebastian Adeberg, Vivek Verma, Angela Paul, Jutta Kappes, Hans Hoffmann, Juergen Debus, Claus P. Heussel & Stefan Rieken. (2017) Parenchymal and Functional Lung Changes after Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer—Experiences from a Single Institution. Frontiers in Oncology 7.
Crossref
Erqi L. Pollom, Alexander L. Chin, Maximilian Diehn, Billy W. Loo & Daniel T. Chang. (2017) Normal Tissue Constraints for Abdominal and Thoracic Stereotactic Body Radiotherapy. Seminars in Radiation Oncology 27:3, pages 197-208.
Crossref
Kangpyo Kim, Jeongshim Lee, Yeona Cho, Seung Yeun Chung, Jason Joon Bock Lee, Chang Geol Lee & Jaeho Cho. (2017) Predictive factors of symptomatic radiation pneumonitis in primary and metastatic lung tumors treated with stereotactic ablative body radiotherapy. Radiation Oncology Journal 35:2, pages 163-171.
Crossref
Jing Zhao, Ellen D. Yorke, Ling Li, Brian D. Kavanagh, X. Allen Li, Shiva Das, Moyed Miften, Andreas Rimner, Jeffrey Campbell, Jinyu Xue, Andrew Jackson, Jimm Grimm, Michael T. Milano & Feng-Ming (Spring) Kong. (2016) Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies. International Journal of Radiation Oncology*Biology*Physics 95:5, pages 1357-1366.
Crossref
Aadel A. Chaudhuri, Michael S. Binkley, Joseph Rigdon, Justin N. Carter, Sonya Aggarwal, Sara A. Dudley, Yushen Qian, Kiran A. Kumar, Wendy Y. Hara, Michael Gensheimer, Viswam S. Nair, Peter G. Maxim, David B. Shultz, Karl Bush, Nicholas Trakul, Quynh-Thu Le, Maximilian Diehn, Billy W. LooJr.Jr. & Haiwei Henry Guo. (2016) Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR). Radiotherapy and Oncology 119:3, pages 454-460.
Crossref
Matthew S. Ning, Joseph M. Kaminski, Darko Pucar & Eric T. Shinohara. (2015) Radiation emergencies: radiation-related brain and lung injury. Journal of Radiation Oncology 5:1, pages 9-17.
Crossref
Louise Murray, Ebru Karakaya, Samantha Hinsley, Mitchell Naisbitt, John Lilley, Michael Snee, Katy Clarke, Hima B Musunuru, Satiavani Ramasamy, Rob Turner & Kevin Franks. (2016) Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity. The British Journal of Radiology 89:1058, pages 20150628.
Crossref
Nobuhide Wakai, Iori Sumida, Yuki Otani, Osamu Suzuki, Yuji Seo, Fumiaki Isohashi, Yasuo Yoshioka, Masatoshi Hasegawa & Kazuhiko Ogawa. (2015) Optimization of leaf margins for lung stereotactic body radiotherapy using a flattening filter-free beam. Medical Physics 42:5, pages 2125-2131.
Crossref
Niccolò Giaj Levra, Andrea Riccardo Filippi, Alessia Guarneri, Serena Badellino, Cristina Mantovani, Enrico Ruffini & Umberto Ricardi. (2015) Efficacy and Safety of Stereotactic Ablative Radiotherapy in Patients with Previous Pneumonectomy. Tumori Journal 101:2, pages 148-153.
Crossref
Yoshiyuki Shioyama, Katsumasa Nakamura & Hiroshi Honda. 2015. Stereotactic Body Radiation Therapy. Stereotactic Body Radiation Therapy 163 173 .
Weijie Xiong, Qingfeng Xu, Yong Xu, Changjin Sun, Na Li, Lin Zhou, Yongmei Liu, Xiaojuan Zhou, Yongsheng Wang, Jin Wang, Sen Bai, You Lu & Youling Gong. (2014) Stereotactic body radiation therapy for post-pulmonary lobectomy isolated lung metastasis of thoracic tumor: survival and side effects. BMC Cancer 14:1.
Crossref
Hideomi Yamashita. (2014) Radiation pneumonitis after stereotactic radiation therapy for lung cancer. World Journal of Radiology 6:9, pages 708.
Crossref
James Welsh, Arya Amini, Katherine Ciura, Ngoc Nguyen, Matt Palmer, Hendrick Soh, Pamela K. Allen, Michael Paolini, Zhongxing Liao, Jaques Bluett, Radhe Mohan, Daniel Gomez, James D. Cox, Ritsuko Komaki & Joe Y. Chang. (2013) Evaluating proton stereotactic body radiotherapy to reduce chest wall dose in the treatment of lung cancer. Medical Dosimetry 38:4, pages 442-447.
Crossref
Cem Altunbas, Brian Kavanagh, Wayne Dzingle, Kelly Stuhr, Laurie Gaspar & Moyed Miften. (2013) Dosimetric errors during treatment of centrally located lung tumors with stereotactic body radiation therapy: Monte Carlo evaluation of tissue inhomogeneity corrections. Medical Dosimetry 38:4, pages 436-441.
Crossref
Eva M. Bongers, Angela Botticella, David A. Palma, Cornelis J.A. Haasbeek, Andrew Warner, Wilko F.A.R. Verbakel, Ben Slotman, Umberto Ricardi & Suresh Senan. (2013) Predictive parameters of symptomatic radiation pneumonitis following stereotactic or hypofractionated radiotherapy delivered using volumetric modulated arcs. Radiotherapy and Oncology 109:1, pages 95-99.
Crossref
Kujtim Latifi, Kenneth M. Forster, Sarah E. Hoffe, Thomas J. Dilling, Wouter van Elmpt, Andre Dekker & Geoffrey G. Zhang. (2013) Dependence of ventilation image derived from 4D CT on deformable image registration and ventilation algorithms. Journal of Applied Clinical Medical Physics 14:4, pages 150-162.
Crossref
Chuxiong Ding, Timothy D. Solberg, Brian Hrycushko, Lei Xing, John Heinzerling & Robert D. Timmerman. (2013) Optimization of normalized prescription isodose selection for stereotactic body radiation therapy: Conventional vs robotic linac. Medical Physics 40:5, pages 051705.
Crossref
Kimberly M. Creach, Issam El Naqa, Jeffrey D. Bradley, Jeffrey R. Olsen, Parag J. Parikh, Robert E. Drzymala, Charles Bloch & Clifford G. Robinson. (2012) Dosimetric predictors of chest wall pain after lung stereotactic body radiotherapy. Radiotherapy and Oncology 104:1, pages 23-27.
Crossref
Yukinori Matsuo, Keiko Shibuya, Mitsuhiro Nakamura, Masaru Narabayashi, Katsuyuki Sakanaka, Nami Ueki, Ken Miyagi, Yoshiki Norihisa, Takashi Mizowaki, Yasushi Nagata & Masahiro Hiraoka. (2012) Dose–Volume Metrics Associated With Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Lung Cancer. International Journal of Radiation Oncology*Biology*Physics 83:4, pages e545-e549.
Crossref
A Takeda, T Ohashi, E Kunieda, N Sanuki, T Enomoto, T Takeda, Y Oku & N Shigematsu. (2012) Comparison of clinical, tumour-related and dosimetric factors in grade 0–1, grade 2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours. The British Journal of Radiology 85:1013, pages 636-642.
Crossref
Matthias Guckenberger, Anthony Kavanagh, Steve Webb & Michael Brada. (2011) A novel respiratory motion compensation strategy combining gated beam delivery and mean target position concept – A compromise between small safety margins and long duty cycles. Radiotherapy and Oncology 98:3, pages 317-322.
Crossref
Bradford S. Hoppe, Soon Huh, Stella Flampouri, Romaine C. Nichols, Kenneth R. Oliver, Christopher G. Morris, Nancy P. Mendenhall & Zuofeng Li. (2010) Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: A dosimetric comparison with photon-based stereotactic body radiotherapy. Radiotherapy and Oncology 97:3, pages 425-430.
Crossref
Clifford G. Robinson & Jeffrey D. Bradley. (2010) The Treatment of Early-Stage Disease. Seminars in Radiation Oncology 20:3, pages 178-185.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.